Skip to main content

Table 4 Health-care outcomes

From: Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center

 

2009 ( n= 2,098)

2010 ( n= 2,790)

P value

Total N

Mean or n

SD or percentage

Total N

Mean or n

SD or percentage

Any PACU time (n,%)

1,977

1,498

75.8

2,774

2,053

74

0.1681

PACU time (hrs, incl. 0) (mean, SD)

1,977

3.2

3.3

2,774

3.2

3.3

0.0848

PACU hrs if > 0 (mean, SD)

1,498

4.3

3.2

2,053

4.3

3.2

0.2991

Any ICU stay (n,%)

1,971

339

17.2

2,774

629

22.7

<0.0001

ICU days

1,971

  

2,774

  

<0.0001

None (n,%)

 

1,632

83

 

2,145

77

<0.0001

1 day (n,%)

 

137

7

 

247

9

0.0150

2 to 3 days (n,%)

 

114

6

 

189

7

0.1530

4+ days (n,%)

 

88

4

 

193

7

0.0003

Total ICU days (incl. 0) (mean, SD)

1,971

0.9

4.8

2,774

1

4.2

<0.0001

ICU days if > 0 (mean, SD)

339

5.2

10.7

629

4.5

7.8

0.3676

Highest postop creatinine (mean, SD)

1,901

1.2

1

2,634

1.4

1.5

0.0884

Creatinine pre-post percentage change (mean, SD)

1,310

24.1

69

1,735

24.1

63.6

0.4533

LOS (days) (mean, SD)

1,977

7.3

9.2

2,774

7.3

9.6

0.8711

Death - 30 days (n,%)

1,977

32

1.6

2,774

49

1.8

0.6981

Death - 1 year (n,%)

1,977

164

8.3

2,774

238

8.6

0.7286

  1. PACU, post-anesthesia care units; postop, postoperative; hrs, hours; SD, standard deviation; ICU, intensive care unit; creatinine pre-post, creatinine pre-surgery post-surgery; LOS, length of stay.